Cobicistat matches ritonavir as atazanavir booster
Black gay men in the UK almost twice as likely to have HIV as white men, meta-analysis shows
Taking isoniazid preventive therapy for one year reduces the risk of TB in people taking antiretroviral therapy
First generic HIV drugs could save US at least $920 million a year
Latest data on HIV cure research
Determine LAM urine antigen TB test is highly cost-effective for use in hospitalised people living with HIV
Dolutegravir matches raltegravir for people starting treatment
HIV treatment for children: how programmes are improving diagnosis and retention
Does injectable hormonal contraception increase the risk of HIV infection?
HIV infection does not compromise multidrug-resistant TB treatment outcomes in Botswana
Mobile technologies playing a growing role in HIV care and treatment support
In the real world HIV has changed; in the courtroom it is still the 1980s
Intellectual property “still a threat,” to antiretroviral access, says panel
Community-based support aids retention, adherence and treatment response
Decompensated liver disease more frequent in HIV/HCV co-infected people
Will MSM use over-the-counter rapid HIV tests to screen sexual partners?
Preventing malaria and diarrhoea delays need for antiretroviral therapy
Transforming ‘PMTCT programmes into ART programmes’: UNICEF champions lifelong treatment for all HIV-positive pregnant women
